GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q3 2024 GSK plc Earnings Call Transcript

Oct 30, 2024 / 12:00PM GMT
Release Date Price: $37.01 (-3.04%)
Operator

Hello, everyone. Welcome to today's call and webcast. The Q3 presentation was sent to our distribution list by e-mail, and you can also find it on gsk.com. Please turn to slide 2. This is the usual safe harbor statement. We will comment on our performance using constant exchange rates, or CER, unless stated otherwise. Please turn to slide 3. Today's call will last approximately 1 hour, with the presentation taking around 30 minutes and the remaining time for your questions.

Our speakers today are Emma Walmsley Luke Miels, Deborah Waterhouse and Julie Brown, with Tony Wood and David Redfern joining for Q&A.

Please ask only one to two questions so that everyone has a chance to participate.

Turning to slide 4. I will now hand the call to Emma.

Emma Walmsley
GSK plc - Chief Executive Officer, Executive Director

Welcome to everybody joining us today. Please turn to the next slide. I'm pleased to report that despite some challenges, this has been a positive quarter for GSK and we're delivering 9% sales growth and 19% profit growth

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot